Biometric ring manufacturer Oura postponed its initial public offering (IPO) on Tuesday due to "uncertainty" in the market environment, a move that surprised Wall Street despite the company's assertion that demand for its shares remained strong.
Analysts say IPO delays are accelerating in 2026, even as Oura faces some company-level questions from the market. The new issuance environment for companies planning to go public has suddenly become a headwind due to soaring bond yields.
Matthew Kennedy, Senior Strategist at IPO-focused firm Renaissance Capital, told CNBC: “We’ve had three or four in a row—a string of delays—that I think really says something about market conditions. You can’t really attribute all four to company-specific issues.”
According to data from Renaissance Capital, four companies from various sectors, each planning to raise at least $50 million, announced delays in their IPOs or withdrew their listing applications entirely over the past week. This brings the total number of such cases in the third quarter to seven, up from four in the second quarter and three in the first quarter.
Before Oura postponed its listing on Tuesday, nuclear component manufacturer Holtec Nuclear withdrew its IPO last Friday; materials company Amaero postponed its IPO last Wednesday; and Bamboo Insurance postponed its IPO on September 22.
Jay Ritter, head of the IPO Initiative at the University of Florida’s Warrington College of Business, said: “I have some sympathy for using market conditions as an excuse—when three well-known companies do it, it clearly isn’t just a company-specific issue.”
The IPO's annual performance remains solid.
Data from Renaissance Capital shows that overall IPO performance remains strong this year, with approximately 110 transactions raising around $146.9 billion, excluding special purpose acquisition companies (SPACs). This includes major offerings in the second quarter by SpaceX and South Korean memory chip manufacturer SK Hynix.
However, this volume represents a 30% decline compared to the same period last year. A total of 202 IPOs occurred in 2025, the highest number since 2021, when nearly 400 took place. This year’s total fundraising increased by 394% year-over-year, driven by offerings from SpaceX, SK Hynix, and Cerebras.
Year-to-date by industry, the healthcare and industrials sectors are tied for the highest number of IPOs, each accounting for 24%; the technology sector ranks third at 18%.
As of now, 59% of all 2026 offerings have traded at or above their IPO offering price; however, it is notable that SpaceX, SK Hynix, and Cerebras have all underperformed relative to their offering prices.
Macroeconomic headwinds
Recently, macroeconomic factors and concerns about AI development have been suppressing the IPO market.
Renaissance analysts wrote in a client report last week: "IPO activity in the third quarter of 2026 fell below expectations due to heightened concerns over AI spending, bond yields reaching a 19-year high, and the resumption of rate hikes, dampening the autumn recovery."
The Renaissance IPO ETF reached its peak in June this year, during SpaceX's IPO.
Gil Luria, Head of Technology Research at DA Davidson, said: “There remains strong enthusiasm for AI-related areas, including large-scale infrastructure development. Demand is high in sectors such as data centers, but this is largely a commodity-style business.”
Analysts say that Oura's business is concentrated on its biometric ring product, so it may also face its own challenges.
Gil Luria, Head of Technology Research at DA Davidson, said: “I would group Peloton, GoPro, Fitbit, and Oura together. Investors have been burned significantly by narrow consumer products, and that’s the reaction Oura is getting now. I don’t think this is necessarily about the technology or its configuration—it’s about being a single consumer product.”
Lawyers focused on public markets say that companies today have more alternative options for raising capital in private markets without necessarily turning to public markets.
Ian Schuman, Head of Capital Markets and Public Companies at Latham & Watkins, said: “The depth and range of private capital and alternative options are now vast, and increasingly complex and diverse. If you don’t achieve the valuation you want, you don’t necessarily need to go public.”
— Reported by Gina Francolla